Cost Ramifications of Increased Reporting of Detectable Plasma HIV-1 RNA Levels by the Roche COBAS AmpliPrep/COBAS TaqMan HIV-1 Version 1.0 Viral Load Test
- 1 August 2010
- journal article
- letter
- Published by Ovid Technologies (Wolters Kluwer Health) in JAIDS Journal of Acquired Immune Deficiency Syndromes
- Vol. 54 (4), 442-443
- https://doi.org/10.1097/qai.0b013e3181d01d1d
Abstract
No abstract availableThis publication has 11 references indexed in Scilit:
- Increased Frequency of HIV-1 Viral Load Blip Rate Observed After Switching From Roche Cobas Amplicor to Cobas Taqman AssayJAIDS Journal of Acquired Immune Deficiency Syndromes, 2009
- Increased Reporting of Detectable Plasma HIV-1 RNA Levels at the Critical Threshold of 50 Copies per Milliliter With the Taqman Assay in Comparison to the Amplicor AssayJAIDS Journal of Acquired Immune Deficiency Syndromes, 2009
- Detection of HIV Type 1 Load by the Roche Cobas TaqMan Assay in Patients with Viral Loads Previously Undetectable by the Roche Cobas Amplicor MonitorClinical Infectious Diseases, 2009
- Long-term consequences of the delay between virologic failure of highly active antiretroviral therapy and regimen modificationAIDS, 2008
- Comparative Evaluation of the Automated Roche TaqMan Real-Time Quantitative Human Immunodeficiency Virus Type 1 RNA PCR Assay and the Roche AMPLICOR Version 1.5 Conventional PCR AssayJournal of Clinical Microbiology, 2007
- Human Immunodeficiency Virus Type 1 (HIV-1) Plasma Load Discrepancies between the Roche COBAS AMPLICOR HIV-1 MONITOR Version 1.5 and the Roche COBAS AmpliPrep/COBAS TaqMan HIV-1 AssaysJournal of Clinical Microbiology, 2007
- Nucleoside Reverse-Transcriptase Inhibitor Dosing Errors in an Outpatient HIV Clinic in the Electronic Medical Record EraClinical Infectious Diseases, 2007
- Evaluation of the clinical sensitivity for the quantification of human immunodeficiency virus type 1 RNA in plasma: Comparison of the new COBAS TaqMan HIV-1 with three current HIV-RNA assays—LCx HIV RNA quantitative, VERSANT HIV-1 RNA 3.0 (bDNA) and COBAS AMPLICOR HIV-1 Monitor v1.5Journal of Virological Methods, 2006
- The Relation of Virologic and Immunologic Markers to Clinical Outcomes after Nucleoside Therapy in HIV-Infected Adults with 200 to 500 CD4 Cells per Cubic MillimeterNew England Journal of Medicine, 1996
- Multicenter Evaluation Of Quantification Methods For Plasma Human Immunodeficiency Virus Type 1 RnaThe Journal of Infectious Diseases, 1994